OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
Laura A. Bolte, Karla A. Lee, Johannes R. Björk, et al.
JAMA Oncology (2023) Vol. 9, Iss. 5, pp. 705-705
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 41

Clinical and translational attributes of immune-related adverse events
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 33

Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 23

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
Jiexi Yan, Lu Yang, Qingmiao Ren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

How to optimize the immune checkpoint blockade therapy for cancers?
Hui Guo, Yuchuan Hou, Chunxi Wang, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 343-348
Open Access | Times Cited: 4

Eating away cancer: the potential of diet and the microbiome for shaping immunotherapy outcome
Ngoc-Trang Adrienne Nguyen, Yan Jiang, Jennifer L. McQuade
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Immunotherapy in melanoma: advances, pitfalls, and future perspectives
Cristina Sorino, Simona Iezzi, Ludovica Ciuffreda, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 4

Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Xin Su, Jian Li, Xiao–Ming Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Tumor immunology and immunotherapy for endometrial cancer
Kosuke Murakami, Shiki Takamura, Kazuhiro Kakimi, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-12
Open Access

The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage
J.-M. L’Orphelin, A. Dompmartin, Brigitte Dréno
Pigment Cell & Melanoma Research (2025) Vol. 38, Iss. 2
Open Access

The discrepancy between managing the disease and a disease management program in systemic melanoma therapy
Matthias Brandlmaier, Peter Koelblinger
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025)
Open Access

The Influence of Vegan, Vegetarian, and Omnivorous Diets on Protein Metabolism: A Role for the Gut–Muscle Axis?
Waed Al-Refai, Stephen Keenan, Donny M. Camera, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1142-1142
Open Access

Die Diskrepanz zwischen reiner Krankheitsbehandlung und einem Disease‐Management‐Programm in der systemischen Melanomtherapie
Matthias Brandlmaier, Peter Koelblinger
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 4, pp. 527-531
Open Access

Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen Chen, Peng Han, Yanping Qing
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103579-103579
Closed Access | Times Cited: 4

Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer
Marco A. De Velasco, Yurie Kura, Kazutoshi Fujita, et al.
International Journal of Urology (2024) Vol. 31, Iss. 4, pp. 307-324
Open Access | Times Cited: 2

Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours
Nina Fuller-Shavel, Jonathan Krell
Current Oncology Reports (2024) Vol. 26, Iss. 2, pp. 164-174
Open Access | Times Cited: 2

MicroRNAs and the Mediterranean diet: a nutri-omics perspective for lung cancer
Roberto Cuttano, Francesco Mazzarelli, Kuku Miriam Afanga, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

The Microbiome in Advanced Melanoma: Where Are We Now?
Dylan D. Fortman, Drew Hurd, Diwakar Davar
Current Oncology Reports (2023) Vol. 25, Iss. 9, pp. 997-1016
Closed Access | Times Cited: 6

Diet effects on colonic health influence the efficacy of Bin1 mAb immunotherapy for ulcerative colitis
Sunil Thomas, Nickey Dilbarov, Joseph F. Kelly, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6

Dietas populares y su impacto en la piel. Una revisión narrativa
Miguel Mansilla‐Polo, Jaime Piquero‐Casals, D. Morgado‐Carrasco
Actas Dermo-Sifiliográficas (2023) Vol. 115, Iss. 4, pp. 374-386
Open Access | Times Cited: 5

[Translated article] Popular Diets and Skin Effects: A Narrative Review
M. Mansilla-Polo, J. Piquero-Casals, D. Morgado-Carrasco
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 4, pp. T374-T386
Open Access | Times Cited: 1

Nutritional modulation of antitumor immunity
Mingeum Jeong, Nicholas Collins
Current Opinion in Immunology (2024) Vol. 87, pp. 102422-102422
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top